Pluvicto (lutetium Lu 177 dotatate) can interact with other meds, but the important details depend a lot on what you’re taking and why. In general, the main interaction issues are:

1) Medicines that affect your “somatostatin” receptors (important)

Pluvicto targets somatostatin receptors (especially SSTR2). Drugs that compete with or block those receptors may reduce Pluvicto’s effectiveness.

Examples (often relevant):

• Somatostatin analogs such as octreotide (including Sandostatin LAR), lanreotide (Somatuline)

What to do: Tell your oncology team and pharmacist exactly what you’re on. Often, these are stopped or adjusted before/around Pluvicto dosing, but the plan is individualized.

2) High-dose calcium/vitamin D? (less direct, but common)

Pluvicto uses radioactive exposure; bone marrow and kidney effects are considerations. Supplements (like calcium/vitamin D) are usually not a direct interaction, but your team may monitor:

• Calcium
• Kidney function
• Blood counts (blood cell levels)

3) Other cancer therapies (depends on timing and type)

Pluvicto is sometimes combined with other treatments (or given sequentially). Interactions are often about overlapping side effects, especially:

• Low blood counts (anemia, low white cells, low platelets)
• Fatigue
• Nausea
• Risk to kidneys/liver

Common meds that may overlap in effect include (examples):

• Chemotherapy
• Radiation
• Other radioisotopes
• Some targeted therapies

4) “Radiation-safety” interactions

Any meds that increase kidney stress or have major renal/hepatic metabolism might matter more, because Pluvicto is eliminated largely via the body’s normal elimination pathways, and your liver/kidneys need to handle treatment safely.

5) Common drug interaction resources won’t capture everything

With radiopharmaceuticals, the biggest “interaction” is often receptor-related (somatostatin analogs) and scheduling/timing, not classic CYP-drug interactions.

To give you the right answer, I need your medication list

Can you paste:

1. All prescription meds (including cancer meds), OTC meds, and supplements
2. Your Pluvicto schedule (when you started; next dose date if you know it)
3. Whether you take octreotide or lanreotide (or any other somatostatin-type injections/therapies)
4. Any major kidney issues or liver issues

Then I can tell you which of your meds are likely to matter, which are usually fine, and what questions to ask your oncology/pharmacy team.